Chromate-induced epimutations in mammalian cells

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 5, 2002, Pages 739-743

  Klein, Catherine B ^a   Su, Lin ^a   Bowser, Darlene ^a   Leszcynska, Joanna ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromate; DNA methylation; gpt transgene; V79 Chinese hamster cells

Indexed keywords

BARIUM DERIVATIVE; CARCINOGEN; CHROMIC ACID; DIETHYLSTILBESTROL; DNA; NICKEL; POTASSIUM CHROMATE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; HEREDITY; MAMMAL CELL; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSGENE; TUMOR SUPPRESSOR GENE; X RAY;

ANIMALIA; BACTERIA (MICROORGANISMS); CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 0036803034     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s5739     Document Type: Article

References (39)

1. IARC. Chromium, nickle and welding. IARC Monogr Eval Carcinog Risks Hum 45:49-508 (1990).
2. Kaltreider RC, Pesce CA, Inhat MA, Lariviere JP, Hamilton JW. Differential effects of arsenic (III) and chromium (VI) on nuclear transcription factor binding. Mol Carcinog 25:219-229 (1999).
3. Liu S, Medvedovic M, Dixon K. Mutational specificity in a shuttle vector replicating in chromium (VI)-treated mammalian cells. Environ Mol Mutagen 33:313-319 (1999).
4. DeFlora S, Bagnasco M, Serra D, Zanacchi P. Genotoxicity of chromium compounds. Mutat Res 238:99-172 (1990).
5. Klein CB. Carcinogenicity and genotoxicity of chromium. In: Toxicology of Metals (Chang LW, ed). Boca Raton, FL:CRC Press, 1996;205-219.
6. Snow ET. Metal carcinogenesis: mechanistic implications. Pharmacol Ther 53:31-65 (1992).
7. McCaffrey J, Wolf CM, Hamilton JW. Effects of the genotoxic carcinogen chromium (VI) on basal and hormone-inducible phosphoenolpyruvate carboxykinase gene expression in vivo: correlation with glucocorticoid- and developmentally-regulated gene expression. Mol Carcinog 10:189-198 (1994).
8. Hamilton JW, Kaltreider RC, Bajenova OV, Inhat MA, McCaffrey J, Turpie BW, Rowell EE, Oh J, Nemeth MJ, Pesce CA, Lariviere. Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ Health Perspect 106:1005-1015 (1998).
9. Kim G, Yurkow EJ. Chromium induces a persistent activation of mitogen-activated protein kinases by redox-sensitive mechanisms in H4 rat hepatoma cells. Cancer Res 56:2045-2051 (1996).
10. Carlisle DL. Pritchard DL, Singh J, Patierno SR. Chromium (VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol Carcinog 25:111-118 (2000).
11. Pritchad DE, Ceryak S, Ha I, Fornsaglio JL, Hartman SK, O'Brien TJ, Pateirno SR. Mechanisms of apoptosis and determination of cell fate in chromium (VI)-exposed populations of telomerase-immortalized human fibroblasts. Cell Growth Diff 12:487-496 (2001).
12. + V79 cell lines differ in their mutagenic response to clastogens. Mutat Res 304:217-228 (1994).
13. Klein CB, Su L, Singh JT, Snow ET. Characterization of gpt deletion mutations in transgenic Chinese hamster cell lines. Environ Mol Mutagen 30:418-428 (1997).
14. Lee YW, Klein CB, Kargacin B, Salnikow K, Kitahara J, Dowjat K, Zhitkovitch A, Christie NT, Costa M. Carcinogenic nickel silences gene expression by chromatin condensation and DNA hypermethylation: a new model of epigenetic carcinogens. Mol Cell Biol 15:2547-2557 (1995).
15. Sutherland JE, Peng W, Zhang Q-W, Costa M. The histone deacetylase inhibitor trichostatin A reduced nickle-induced gene silencing inyeast and mammalian cells. Mutat Res 479:225-233 (2001).
16. Su L, Klein CB. Molecular mechanisms of gene inactivation by different mutagens [Abstract]. Proc Am Assoc Cancer Res 40:546 (1999).
17. Klein CB, Rossman, TG. Transgenic Chinese hamster cell lines which exhibit variable levels of gpt mutagenesis. Environ Mol Mutagen 16:1-12 (1990).
18. Klein C, Broday L, Costa M. In vitro genotoxicity assays. Mammalian mutagenesis. In: Current Protocols in Toxicology, Vol 1 (Maines MD, Costa LG, Reed DJ, Sassa S, Sipes I, eds). New York: John Wiley & Sons, 1999;3.3.1-3.3.7.
19. + Chinese hamster cell lines [Abstract]. Environ Mol Mutagen 19:29a (1992).
20. Klein CB, Su L, Kargacin B, Cosentino S, Snow ET, Costa M. Metal mutagenesis in transgenic Chinese hamster cell lines. Environ Health Perspect 102(suppl 4):63-67 (1994).
21. Kargacin B, Klein CB, Costa M. Mutagenic responses of nickel oxides and nickel sulfides in Chinese hamster V79 cell lines at the xanthine-guanine phosphoribosyl transferase locus. Mutat Res 300:63-72 (1993).
22. Yan JL, Hsieh YC, Wu CW, Lee TC. Mutational specificity of chromium (VI) compounds at the hprt locus of Chinese hamster ovary-K1 cells. Carcinogenesis 13:2503-2557 (1992).
23. Cheng L, Liu S, Dixon K. Analysis of repair and mutagenesis of chromium-induced DNA damage in yeast, mammalian cells, and transgenic mice. Environ Health Perspect 106(suppl 4):1027-1032 (1998).
24. Abu-Shakra A, Su L, Harris CE, Klein CB. Unpublished data.
25. Chen J, Thilly WG. Mutational spectrum of chromium (VI) in human cells. Mutat Res 323:21-27 (1994).
26. Liu S, Dixon K. Induction of mutagenic DNA damage by chromium (VI) and glutathione. Environ Mol Mutagen 28:71-79 (1996).
27. Lefevbre Y, Pezerat H. Reactive oxygen species generated from chromate pigments and ascorbate. Environ Mol Mutagen 104(suppl 3):243-245 (1994).
28. Cohen MD, Zelikoff JT, Chen L-C, Schlesinger, RB. Immunotoxic effects of inhaled chromium: role of particle solubility and co-exposure to ozone. Toxicol Appl Pharmacol 152:30-40 (1998).
29. Bennicelli C, Camoirano A, Petruzzelli S, Zanacchi P, DeFlora S. High sensitivity of Salmonella TA102 in detecting hexavalent chromium mutagenecity and its reversal by liver and lung preparations. Mutat Res 122:1-5 (1983).
30. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274:430-432 (1996).
31. Chen JX, Zheng Y, West M, Tang MS. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots. Cancer Res 58:2070-2075 (1998).
32. Pfeifer GP. p53 mutational spectra and the role of methylated CpG sequences. Mutat Res 450:155-166 (2000).
33. Robertson KD, Jones PA. DNA methylation: past, present and future directions. Carcinogenesis 21:461-467 (2000).
34. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MST1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55:4525-4530 (1995).
35. Esteller M, Catasus L, Matias-Guiu X, Mutter GL, Prat J, Baylin SB, Herman JG. hMLH1 promoter hypermethylation is an early event in human endometrial carcinogenesis. Am J Pathol 155:1767-1772 (1999).
36. Bearzatto A, Szadkowski M, Macpherson P, Jiricny J, Karran P. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents. Cancer Res 60:3262-3270 (2000).
37. Horikawa I, Cable PL, Barrett JC. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59:826-830 (1999).
38. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, et al. Methyltransferase recruitment and DNA hypermethylation of target promotors by an oncogenic transcription factor. Science 295:1079-1082 (2002).
39. Costa M, Klein CB. Nickel carcinogenesis, mutation, epigenetics or selection [Editorial]. Environ Health Perspect 107:A438-A439 (1999).